This indicator measures the proportion of children under the age of five who experienced fever within the two weeks prior to the survey and received antimalarial medication. It highlights the accessibility and efficacy of healthcare interventions in managing febrile illnesses, particularly malaria, which is a leading cause of morbidity in young children. By analyzing this data, public health officials can assess the coverage of antimalarial treatments, identify potential gaps in healthcare delivery, and evaluate the effectiveness of health education programs. Increasing this percentage is vital, as timely treatment can significantly reduce the risk of severe complications and improve overall child health outcomes, contributing to broader strategies aimed at reducing child mortality rates.
Source: